JENNIFER GOMEZ: Open Payments
NPI 1043633597 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,491 in 91 payments from 17 companies in 2025. Trend: 2023 $2,129 · 2024 $2,069 · 2025 $1,491
Food & beverage: $1,491
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $370 |
| AstraZeneca Pharmaceuticals LP | 9 | $252 |
| GlaxoSmithKline, LLC. | 20 | $187 |
| Novo Nordisk Inc | 11 | $157 |
| Exact Sciences Corporation | 6 | $92 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Lilly USA, LLC | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Edwards Lifesciences Corporation | 1 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
Products named: VRAYLAR, TRELEGY ELLIPTA, FARXIGA, UBRELVY, AIRSUPRA, Cologuard Collection Kit, QULIPTA, Sunosi.
Industry payments across AZ — which companies pay providers there.
